Log in
Enquire now
‌

US Patent 11364230 Amlodipine formulations

Patent 11364230 was granted and assigned to Azurity Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Azurity Pharmaceuticals
Azurity Pharmaceuticals
Current Assignee
Azurity Pharmaceuticals
Azurity Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11364230
Date of Patent
June 21, 2022
Patent Application Number
17194016
Date Filed
March 5, 2021
Patent Citations
‌
US Patent 10894039 Amlodipine formulations
‌
US Patent 10695329 Amlodipine formulations
‌
US Patent 10799453 Amlodipine formulations
‌
US Patent 10952998 Amlodipine formulations
Patent Citations Received
0
‌
US Patent 11918685 Amlodipine formulations
0
Patent Primary Examiner
‌
Layla Soroush
CPC Code
‌
A61K 31/4422

Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11364230 Amlodipine formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.